Journal
NEURO-ONCOLOGY ADVANCES
Volume 4, Issue 1, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/noajnl/vdab180
Keywords
EGFRvIII; genomic instability; glioblastoma; irinotecan sensitivity; replication stress; R-loops
Categories
Funding
- Federal Ministry of Education and Research (BMBF) [02NUK032]
- University Cancer Center Hamburg Research Fellowship
- Wilhelm Sander-Stiftung
- Fordergemeinschaft Kinderkrebszentrum Hamburg
- E.W. KuhlmannStiftung
- Werner-Otto-Stiftunfg
Ask authors/readers for more resources
This study reveals that the expression of EGFRvIII in a type of brain glioblastoma leads to increased replication stress, as well as genomic instability. These findings may provide new insights for the treatment of glioblastoma.
Background The oncogene epidermal growth factor receptor variant III (EGFRvIII) is expressed in approximately one-third of all glioblastomas (GBMs). So far it is not clear if EGFRvIII expression induces replication stress in GBM cells, which might serve as a therapeutical target. Methods Isogenetic EGFRvIII- and EGFRvIII+ cell lines with endogenous EGFRvIII expression were used. Markers of oncogenic and replication stress such as gamma H2AX, RPA, 53BP1, ATR, and CHK1 were analyzed using western blot, immunofluorescence, and flow cytometry. The DNA fiber assay was performed to analyze replication, transcription was measured by incorporation of EU, and genomic instability was investigated by micronuclei and CGH-Array analysis. Immunohistochemistry staining was used to detect replication stress markers and R-loops in human GBM samples. Results EGFRvIII+ cells exhibit an activated replication stress response, increased spontaneous DNA damage, elevated levels of single-stranded DNA, and reduced DNA replication velocity, which are all indicative characteristics of replication stress. Furthermore, we show here that EGFRvIII expression is linked to increased genomic instability. EGFRvIII-expressing cells display elevated RNA synthesis and R-loop formation, which could also be confirmed in EGFRvIII-positive GBM patient samples. Targeting replication stress by irinotecan resulted in increased sensitivity of EGFRvIII+ cells. Conclusion This study demonstrates that EGFRvIII expression is associated with increased replication stress, R-loop accumulation, and genomic instability. This might contribute to intratumoral heterogeneity but may also be exploited for individualized therapy approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available